138 related articles for article (PubMed ID: 12352359)
21. Plasma androgen responce to hCG stimulation in prepubertal boys with hypospadias and cryptorchidism.
Walsh PC; Curry N; Mills RC; Siiteri PK
J Clin Endocrinol Metab; 1976 Jan; 42(1):52-9. PubMed ID: 2616
[TBL] [Abstract][Full Text] [Related]
22. Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.
Trbovich AM; Martinelle N; O'Neill FH; Pearson EJ; Donahoe PK; Sluss PM; Teixeira J
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):199-208. PubMed ID: 15555913
[TBL] [Abstract][Full Text] [Related]
23. Endocrine screening in 32 consecutive patients with hypospadias.
Feyaerts A; Forest MG; Morel Y; Mure PY; Morel-Journel N; Mallet D; Nicolino M; Chatelain P; David M; Mouriquand P
J Urol; 2002 Aug; 168(2):720-5; discussion 725. PubMed ID: 12131359
[TBL] [Abstract][Full Text] [Related]
24. The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.
Misra M; MacLaughlin DT; Donahoe PK; Lee MM
J Clin Endocrinol Metab; 2003 Feb; 88(2):787-92. PubMed ID: 12574214
[TBL] [Abstract][Full Text] [Related]
25. Low risk of impaired testicular Sertoli and Leydig cell functions in boys with isolated hypospadias.
Rey RA; Codner E; Iñíguez G; Bedecarrás P; Trigo R; Okuma C; Gottlieb S; Bergadá I; Campo SM; Cassorla FG
J Clin Endocrinol Metab; 2005 Nov; 90(11):6035-40. PubMed ID: 16131574
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of steroidogenesis in Leydig cells by Müllerian-inhibiting substance.
Fynn-Thompson E; Cheng H; Teixeira J
Mol Cell Endocrinol; 2003 Dec; 211(1-2):99-104. PubMed ID: 14656482
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of androstenedione in skin and serum levels of gonadotrophins and androgens in prepubertal boys with hypospadias.
Svensson J; Eneroth P; Gustafsson JA; Ritzén M; Stenberg A
J Endocrinol; 1978 Mar; 76(3):399-409. PubMed ID: 564935
[TBL] [Abstract][Full Text] [Related]
28. Serum müllerian-inhibiting substance levels during normal menstrual cycles.
Cook CL; Siow Y; Taylor S; Fallat ME
Fertil Steril; 2000 Apr; 73(4):859-61. PubMed ID: 10731554
[TBL] [Abstract][Full Text] [Related]
29. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
30. Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens.
Houk CP; Pearson EJ; Martinelle N; Donahoe PK; Teixeira J
Endocrinology; 2004 Mar; 145(3):1269-75. PubMed ID: 14630719
[TBL] [Abstract][Full Text] [Related]
31. Thyroid hormone and follicle-stimulating hormone regulate Müllerian-inhibiting substance messenger ribonucleic acid expression in cultured neonatal rat Sertoli cells.
Arambepola NK; Bunick D; Cooke PS
Endocrinology; 1998 Nov; 139(11):4489-95. PubMed ID: 9794457
[TBL] [Abstract][Full Text] [Related]
32. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement.
Rey RA; Belville C; Nihoul-Fékété C; Michel-Calemard L; Forest MG; Lahlou N; Jaubert F; Mowszowicz I; David M; Saka N; Bouvattier C; Bertrand AM; Lecointre C; Soskin S; Cabrol S; Crosnier H; Léger J; Lortat-Jacob S; Nicolino M; Rabl W; Toledo SP; Baş F; Gompel A; Czernichow P; Josso N
J Clin Endocrinol Metab; 1999 Feb; 84(2):627-31. PubMed ID: 10022428
[TBL] [Abstract][Full Text] [Related]
34. Serum Müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome.
Siow Y; Kives S; Hertweck P; Perlman S; Fallat ME
Fertil Steril; 2005 Oct; 84(4):938-44. PubMed ID: 16213847
[TBL] [Abstract][Full Text] [Related]
35. Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation.
Salva A; Hardy MP; Wu XF; Sottas CM; MacLaughlin DT; Donahoe PK; Lee MM
Biol Reprod; 2004 Mar; 70(3):600-7. PubMed ID: 14585814
[TBL] [Abstract][Full Text] [Related]
36. [Anti-Müllerian hormone (AMH) measurements in the assessment of testicular function in prepubertal boys and in sexual differentiation disorders].
Szarras-Czapnik M; Gajewska M; Ksiazyk J; Janas R; Ginalska-Malinowska M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):195-9. PubMed ID: 17020655
[TBL] [Abstract][Full Text] [Related]
37. Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.
Chu MC; Carmina E; Wang J; Lobo RA
Fertil Steril; 2005 Dec; 84(6):1685-8. PubMed ID: 16359965
[TBL] [Abstract][Full Text] [Related]
38. Lack of defects in androgen production in children with hypospadias.
Holmes NM; Miller WL; Baskin LS
J Clin Endocrinol Metab; 2004 Jun; 89(6):2811-6. PubMed ID: 15181062
[TBL] [Abstract][Full Text] [Related]
39. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.
Seifer DB; MacLaughlin DT; Christian BP; Feng B; Shelden RM
Fertil Steril; 2002 Mar; 77(3):468-71. PubMed ID: 11872196
[TBL] [Abstract][Full Text] [Related]
40. Sex-specific fetal lung development and müllerian inhibiting substance.
Catlin EA; Powell SM; Manganaro TF; Hudson PL; Ragin RC; Epstein J; Donahoe PK
Am Rev Respir Dis; 1990 Feb; 141(2):466-70. PubMed ID: 2301861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
